Our Response to COVID-19
Last updated: 15th June 2020
As the COVID-19 pandemic continues to take effect across the UK, we find ourselves in increasingly challenging times. Each and every one of us is having to change the way we live, work and plan for a future with many uncertainties.
As we navigate this challenge together, our highest priority at Bristol Myers Squibb remains the patients and healthcare professionals we serve. We are fully committed to supporting all those affected in the most responsible way possible.
In parallel, we are taking significant steps to protect the health and safety of our workforce, allowing critical functions to continue, and ensuring that there is no or minimal disruption to the supply of our medicines. Our team are working tirelessly to support relief efforts across the UK.
As the situation here in the UK, we will take all necessary steps to protect and support the wellbeing of patients, people and the communities we serve.
Frequently Asked Questions
How is COVID-19 affecting the supply of Bristol Myers Squibb medicines?
How is COVID-19 affecting Bristol Myers Squibb clinical trials and ongoing research efforts?
How is Bristol Myers Squibb protecting its workforce?
How is Bristol Myers Squibb protecting healthcare providers?
Where can patients go for questions about COVID-19 treatment and Bristol Myers Squibb medicines?
How is Bristol Myers Squibb contributing to the UK relief efforts for COVID-19?
Date of preparation: June 2020; NOUK2000581-02